A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia

Author： Schwartzberg L.   Shiffman R.   Tomita D.   Stolshek B.   Rossi G.   Adamson R.  

Publisher： Elsevier

ISSN： 0149-2918

Source： Clinical Therapeutics, Vol.25, Iss.11, 2003-11, pp. : 2781-2796

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Spotlight on Darbepoetin Alfa in the Treatment of Anemia in Patients with Cancer Receiving Chemotherapy

By Siddiqui M. Asif A.   Keating Gillian M.  

BioDrugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 321-323

Adis International

Access to resources Recommend Favorite

Darbepoetin Alfa: Its Use in Anemia Associated with Chronic Kidney Disease

By Robinson Dean M.   Easthope Stephanie E.  

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 327-343

Adis International

Access to resources Recommend Favorite

Octocog Alfa (Advate®): A Guide to Its Use in Hemophilia A

By Keating Gillian M.   Dhillon Sohita  

BioDrugs, Vol. 26, Iss. 4, 2012-08 ,pp. : 269-273

Adis International

Access to resources Recommend Favorite

Implementation of best practice for chemotherapy-induced nausea and vomiting in an acute care setting

By Chung Su Kyoung   Ahn Mee Jung   Yoo Jae Yong   Choi Mona   Hyang Na   Woo So Rah   Kim So-Sun   Kim Sun Ah   Oh Eui Geum  

International Journal of Evidence-based Healthcare, Vol. 9, Iss. 1, 2011-03 ,pp. : 32-38

Blackwell Publishing

Access to resources Recommend Favorite

Agalsidase Alfa: A Review of its Use in the Management of Fabry Disease

By Keating Gillian M.  

BioDrugs, Vol. 26, Iss. 5, 2012-10 ,pp. : 335-354

Adis International

Access to resources Recommend Favorite